GSTM1 and hemoglobin E disease: Four studies focused on β-thalassemia/Hb E disease patients [20,21,22,50], four on β-thalassemia [37,38,49,54], one on both β-thalassemia and Hb H/CS patients (28), and one on a non-specific type of thalassemia [14].